ophthalmology trb chemedica 2552x771
tear film visualization trb english

Dry eye disease,
a well-known “civilization disease”

Launched more than 20 years ago, our hyaluronic acid-based lubricant eye drops meet high compliance and patient satisfaction.

Affecting between 5% and 34% of people worldwide, Dry eye disease represents a significant economic burden due to direct and indirect healthcare costs such as reduced work productivity.1,2,3 We have developed the VISMED® range of lubricant eye drops consisting in hypo-osmolar sodium hyaluronate solutions indicated for the treatment of symptoms and signs of dry eye, ocular surface damage and eye irritation due to different diseases such as superficial keratitis, Sjögren’s syndrome, or primary dry eye syndrome.4-6 The VISMED® product range has been formulated in order to break the vicious cycle of dry eye by counteracting tear hyperosmolarity and stabilising the tear film.7 With a choice of sodium hyaluronate concentrations varying from 0.1% to 0.3%, we offer an adaptable range of concentrations to meet the patient’s specific needs.

Operation room during eye surgery with Vismed Eye drops TRB Chemedica

Ophthalmologic surgical relief

Patients can benefit from TRB Chemedica experience and products with proven efficacy and safety by reducing complications during or after cataract surgery.

Cataract surgery is among the most common and most successful surgical procedures performed today.8 VISIOL®, a sodium hyaluronate solution containing mannitol has been developed by our team to improve protection against endothelial damage and to preserve tissue integrity and provide good visibility during surgery of the anterior segment of the eye such as cataract surgery, intraocular lens implantation, corneal transplantation surgery and glaucoma filtering surgery. 9-10 Easy product handling during the surgery allows a quick and safe surgery with an optimal outcome for the patients.10

Find out more on your local website about our medicine for dry eye and ocular surgery

Learn more